Pain News and Research

Latest Pain News and Research

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

Study reveals relationship between migraine and low income status

Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.

29 Aug 2013

Johns Hopkins researchers use low-energy light to solve serious heart problems

When a beating heart slips into an irregular, life-threatening rhythm, the treatment is well known: deliver a burst of electric current from a pacemaker or defibrillator. But because the electricity itself can cause pain, tissue damage and other serious side-effects, a Johns Hopkins-led research team wants to replace these jolts with a kinder, gentler remedy: light.

29 Aug 2013

Patients attending specialist nurse clinics do not get inferior treatment to that offered by rheumatologists

Patients attending clinical nurse specialist clinics do not get inferior treatment to that offered by consultant rheumatologists, the results of a major new clinical trial have revealed.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

TAP block procedure poses no significant risks to patients and cuts postoperative use of narcotics

Surgeons at University Hospitals Case Medical Center, Cleveland, are working to reduce serious complications that have been known to occur with colorectal operations.

29 Aug 2013

Ingestion of strong opioids can cause central nervous system depression, death in young children

Medication poisonings among children are an important public health problem. During 2010-2011, an average of 1500 children under 6 years of age was evaluated in emergency departments each year due to unintentional exposure to buprenorphine. Ingestion of strong opioids, such as buprenorphine, can cause central nervous system depression, respiratory depression, and death in young children.

29 Aug 2013

Experts share tips on preventing ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

29 Aug 2013

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Symptoms of vulvovaginal atrophy (VVA), such as lack of lubrication, irritated tissues, painful urination, and pain with intercourse, affect as many as 45% of women after menopause.

29 Aug 2013

Researchers develop new opioid drug for chronic pain

A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, has developed a new opioid drug that shows great potential to advance treatment and improve quality of life for individuals living with chronic pain.

29 Aug 2013

Endo Eyes Generics Growth With $225M Boca Pharmacal Acquisition

...

28 Aug 2013

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.

28 Aug 2013

Health Union publishes RA in America 2013 survey results

Health Union, LLC announced today that it has published detailed results from the "RA in America 2013" survey on its newly launched website http://RheumatoidArthritis.Net. The survey covered a broad array of topics impacting people with Rheumatoid Arthritis (also called RA), and was taken by 1,055 respondents making it one of the largest of its kind conducted with RA patients in the United States.

28 Aug 2013

New polymer additives enhance ability of oral drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed — a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

28 Aug 2013

New compound offers way to treat migraine and other disorders of central nervous system

For many migraine sufferers, bright lights are a surefire way to exacerbate their headaches. And for some night-shift workers, just a stroll through a brightly lit parking lot during the morning commute home can be enough to throw off their body's daily rhythms and make daytime sleep nearly impossible. But a new molecule that selectively blocks specialized light-sensitive receptors in the eyes could help both these groups of people, without affecting normal vision.

28 Aug 2013

Lipidor announces positive results from Phase I/IIa study of AKVANO/calcipotriol for psoriasis vulgaris

Today Lipidor announced positive results from a Phase I/IIa study investigating the efficacy and tolerability of its AKVANO/calcipotriol spray formulation for the treatment of psoriasis vulgaris, the most common form of psoriasis.

27 Aug 2013

University of Utah started construction on Ray and Tye Noorda Oral Health Education Building

The University of Utah on Friday, Aug. 23, 2013, broke ground on the $36.4 million Ray and Tye Noorda Oral Health Education Building, which when completed in December 2014 will house the University's new School of Dentistry.

27 Aug 2013

$Coordinator-based FLS helps identify, manage people at high risk of secondary fractures$

Coordinator-based FLS helps identify, manage people at high risk of secondary fractures

...

27 Aug 2013

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

27 Aug 2013

Brain's tactile and motor neurons shape internal spatial image of body

The brain's tactile and motor neurons, which perceive touch and control movement, may also respond to visual cues, according to researchers at Duke Medicine.

27 Aug 2013

Pain News and Research

Latest Pain News and Research

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Study reveals relationship between migraine and low income status

Johns Hopkins researchers use low-energy light to solve serious heart problems

Patients attending specialist nurse clinics do not get inferior treatment to that offered by rheumatologists

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

TAP block procedure poses no significant risks to patients and cuts postoperative use of narcotics

Ingestion of strong opioids can cause central nervous system depression, death in young children

Experts share tips on preventing ovarian cancer

NAMS publishes new guidance for diagnosing and treating vulvovaginal atrophy

Researchers develop new opioid drug for chronic pain

Endo Eyes Generics Growth With $225M Boca Pharmacal Acquisition

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Health Union publishes RA in America 2013 survey results

New polymer additives enhance ability of oral drugs to reach bloodstream

New compound offers way to treat migraine and other disorders of central nervous system

Lipidor announces positive results from Phase I/IIa study of AKVANO/calcipotriol for psoriasis vulgaris

University of Utah started construction on Ray and Tye Noorda Oral Health Education Building

Coordinator-based FLS helps identify, manage people at high risk of secondary fractures

FDA grants Priority Review designation to sNDA for Nexavar tablets

Brain's tactile and motor neurons shape internal spatial image of body

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in